Rosemont, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Orthopaedic Research and Education Foundation, founded in 1955, is a community nonprofit in the Medical Research sector that reported $4.7M in total revenue in fiscal year 2024. Revenue grew 10% year-over-year, indicating healthy expansion. Expenses of $6.2M exceeded revenue, resulting in a 32% operating deficit.
The Orthopaedic Research and Education Foundation (OREF) mission is improving lives by supporting excellence in orthopaedic research. OREF's vision is that it will be the leader in supporting orthopaedic research to improve function, eliminate pain and restore mobility.
Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in...
Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in basic science/translation, clinical, and health services research.
OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to...
OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to help them successfully pursue research careers.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,671,069 | $4,255,766 | +0.1% |
| Expenses | $6,171,537 | $5,238,185 | +0.2% |
| Net Income | $-1,500,468 | $-982,419 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Joshua J Jacobs MD | President | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Thomas P Sculco MD | Past President | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Richard F Kyle MD | Past President | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Andrew N Pollak MD | President Elect | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| James R Ficke MD | 2nd President Elect | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Karen L Hackett | Secretary / Treasurer | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Francis Y Lee MD PhD | Chair RGC | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jeffrey S Abrams MD | Chair, Innovations & Partn | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Richard F Santore MD | Chair-Individual Developme | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jeremie M Axe MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Nicholas M Bernthal MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Daniel J Berry MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Michael P Bolognesi MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| John D Kelly IV MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| David C Templeman MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Ivan Tormos | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Stuart Weinstein MD | Trustee | 5.00 |
Director
|
$0 | $0 | $0 |
| Rhonda Dirr | Executive Director | 40.00 |
Officer
|
$116,041 | $23,420 | $139,461 |
| Lee Grossman | CEO | 40.00 |
Officer
|
$308,549 | $60,547 | $369,096 |
| Dan Krupp | Corporate Relations/Innova | 40.00 |
Highest
|
$153,497 | $44,193 | $197,690 |
| Deborah Cummins | VP of Research and Grants | 40.00 |
Highest
|
$150,845 | $46,792 | $197,637 |
| Carmen Metoyer | VP of Development | 40.00 |
Highest
|
$105,098 | $13,867 | $118,965 |
| Karen Pubentz | Sr. Director of Communicat | 40.00 |
Highest
|
$148,566 | $26,553 | $175,119 |
| John Johnson | Campaigns Director | 1.00 |
Highest
|
$134,357 | $13,234 | $147,591 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,671,069 | $6,171,537 | $20,002,839 | $-1,500,468 |
| 2024 | $4,255,766 | $5,238,185 | $21,495,900 | $-982,419 |
| 2023 | $3,641,953 | $5,574,158 | $22,252,031 | $-1,932,205 |
| 2022 | $3,972,441 | $4,263,330 | $22,322,488 | $-290,889 |
| 2021 | $3,855,378 | $3,507,955 | $25,903,586 | $347,423 |
| 2020 | $4,436,812 | $5,424,944 | $23,173,135 | $-988,132 |
| 2019 | $3,672,082 | $4,946,601 | $23,718,387 | $-1,274,519 |
| 2018 | $6,087,726 | $5,187,501 | $25,537,755 | $900,225 |
Compare Orthopaedic Research and Education Foundation with other nonprofits in Illinois and across the country.